EFFICACY AND SAFETY OF TOFACITINIB RETREATMENT FOR ULCERATIVE COLITIS AFTER TREATMENT INTERRUPTION: AN UPDATE OF RESULTS FROM THE OCTAVE CLINICAL TRIALS

Julian Panés  1     Jean-Frederic Colombel  2     Severine Vermeire  3     Marla C. Dubinsky  2     Ala I. Sharara  4     Nervin Lawendy  5     Wenjin Wang     Leonardo Salese     Chinyu Su     Irene Modesto     Xiang Guo     Edward V. Loftus Jr.    
1 Hospital Clínic de Barcelona, IDIBAPS, CIBERehd,Barcelona,Spain
2 Icahn School of Medicine at Mount Sinai,New York,United States
3 University Hospitals Leuven,Leuven,Belgium
4 American University of Beirut Medical Center,Beirut,Lebanon
5 Pfizer Inc,Collegeville, PA,United Sta

Session
IBD (Posters)

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing